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Incorporation of Phosphorylcholine into the Lipooligosaccharide of
Nontypeable Haemophilus influenzae Does Not Correlate with the
Level of Biofilm Formation In Vitro
Carmen Puig,a,b,c Sara Marti,a,b,c Peter W. M. Hermans,b* Marien I. de Jonge,b Carmen Ardanuy,a,c Joseﬁna Liñares,a,c
Jeroen D. Langereisb
Microbiology Department, Hospital Universitari de Bellvitge-Universitat de Barcelona, IDIBELL, Barcelona, Spaina; Laboratory of Pediatric Infectious Diseases, Department
of Pediatrics, Radboud University Medical Center, Nijmegen, The Netherlandsb; CIBER de Enfermedades Respiratorias, ISCIII, Madrid, Spainc
Nontypeable Haemophilus influenzae (NTHi) is an opportunistic pathogen that causes otitis media in children and community-
acquired pneumonia or exacerbations of chronic obstructive pulmonary disease in adults. A large variety of studies suggest that
biofilm formation by NTHi may be an important step in the pathogenesis of this bacterium. The objective of this report was to
determine the relationship between the presence of phosphorylcholine in the lipooligosaccharide of NTHi and the level of bio-
film formation. The study was performed on 111 NTHi clinical isolates collected from oropharyngeal samples of healthy chil-
dren, middle ear fluid of children with otitis media, and sputum samples of patients with chronic obstructive pulmonary disease
or community-acquired pneumonia. NTHi clinical isolates presented a large variation in the level of biofilm formation in a static
assay and phosphorylcholine content. Isolates collected from the oropharynx andmiddle ear fluid of children tended to have
more phosphorylcholine andmade denser biofilms than isolates collected from sputum samples of patients with chronic ob-
structive pulmonary disease or community-acquired pneumonia. No correlation was observed between biofilm formation and
the presence of phosphorylcholine in the lipooligosaccharide for either planktonic or biofilm growth. This lack of correlation
was confirmed by abrogating phosphorylcholine incorporation into lipooligosaccharide through licA gene deletion, which had
strain-specific effects on biofilm formation. Altogether, we present strong evidence to conclude that there is no correlation be-
tween biofilm formation in a static assay and the presence of phosphorylcholine in lipooligosaccharide in a large collection of
clinical NTHi isolates collected from different groups of patients.
Haemophilus influenzae is a Gram-negative human-restrictedpathogen that forms part of the normal nasopharyngeal mi-
crobiota (1). This species has been classified into two different
groups depending on the absence or presence of the polysaccha-
ride capsule (serotypes a to f). Serotype b, as the most invasive
serotype, was responsible for invasive diseases in children before
the introduction of the successful type b polysaccharide-protein
conjugate vaccine in developed countries (2). The second group,
commonly known as nontypeable H. influenzae (NTHi), is
formed by strains lacking the capsular structure. NTHi usually
colonizes the nasopharynx asymptomatically in healthy individu-
als; nevertheless, this opportunistic pathogen is a frequent cause of
otitis media (OM), sinusitis, conjunctivitis, community-acquired
pneumonia (CAP), and exacerbations of chronic obstructive pul-
monary disease (COPD) (3–5).
Chronic infections have been widely associated with the pres-
ence of biofilm-forming bacteria (6). Biofilm is defined as a com-
munity of microorganisms held together in a polymeric matrix
and attached to an inert or living surface (7). This biofilm struc-
ture confers protection against the host immune system but also
increases antimicrobial resistance (8–10). Despite controversial
views with respect to the presence of a specific polymeric matrix
(11) or biofilm formation as a controlled survival mechanism
(12), NTHi biofilms are suggested to be present during coloniza-
tion, OM, and exacerbations of COPD (13–15).
Various bacterial factors have been shown to affect NTHi bio-
film formation (16), including the presence of sialic acid (NeuAc)
(17) and phosphorylcholine (PCho) incorporation into the lipoo-
ligosaccharide (LOS) (18). Hong and coworkers presented con-
vincing data where they correlated the presence of PCho in the
LOS of three variants of NTHi strain 2019 with biofilm matura-
tion in a continuous flow system in vitro as well as in a chinchilla
model of OM in vivo (19). In that study, a licD gene deletion
mutant deficient for PCho showed decreased biofilm formation,
whereas a phase-locked licA gene variant showed increased PCho
incorporation and increased biofilm maturation compared to
wild-type (WT) strain 2019. These results corroborate recent find-
ings byMorey et al., who showed decreased biofilm formation for
a lic1 mutant of NTHi strain 375 (20). Furthermore, NTHi licD
mutants of strains 2019 and 86-028NP showed decreased biofilm
density and increased clearance in a chinchilla model for OM
compared to WT strains (18, 19).
The ability of NTHi to form biofilms in vitro is highly strain
specific (21–24), but the mechanism that determines whether a
particular strain is able to form a biofilm is not known. Based on
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those previous studies, our work aimed to investigate whether the
presence of PCho was associated with the level of biofilm forma-
tion by clinical NTHi strains isolated from the oropharynx of
healthy children, middle ear fluid of children with OM, and spu-
tum of adult patients with COPD and CAP.
MATERIALS AND METHODS
Bacterial strains and culture conditions. One hundred eleven NTHi
strains from different groups of patients were analyzed in this study: (i) 29
isolates from the oropharynx of healthy children in day care centers in
Oviedo, Spain; (ii) 25 isolates from middle ear fluid of children with OM
at the Radboud University Medical Centre, Nijmegen, The Netherlands;
(iii) 27 isolates from sputum samples collected fromCOPDpatients at the
Hospital Universitari de Bellvitge, Barcelona, Spain; and (iv) 30 isolates
from sputum samples of patients withCAP from theHospitalUniversitari
de Bellvitge, Barcelona, Spain. All the NTHi isolates were identified ac-
cording to standard microbiological procedures (25). All strains used in
this study are reported in Table 1. The strains were grown in brain heart
infusion (BHI) medium (Becton, Dickinson) supplemented with 10
g/ml hemin (Sigma-Aldrich) and 10 g/ml NAD (Merck).
Static biofilm formation assay. Bacterial cultures grown overnight
were diluted to a final optical density at 620 nm (OD620) of 0.01 in 150 l
of fresh supplemented BHI (sBHI) broth in 96-well plates or 24-well
plates with glass slides in triplicate and incubated at 37°C in 5%CO2 for 24
h. Before biofilm staining, the OD620 was determined to assess bacterial
growth.Culture brothwas removed, thewells were rinsed three timeswith
distilled water, and glass slides were transferred to new 24-well plates.
Biofilm was stained with 150 l of 0.5% crystal violet for 20 min at room
temperature and washed three times with distilled water to eliminate
traces of unbound dye. Finally, the crystal violet was dissolved with 150l
of 90% ethanol, and the A560 was measured. The experiments were per-
formed on three independent replicates.
Generation of NTHi-directed licAmutants.Deletion of the licA gene
was performed by allelic exchange of the target gene with an antibiotic
resistance marker, as described previously (26), with the primers (Biole-
gio) listed in Table 1. Flanking regions (1,000 bp) of the R2866 licA gene
and the spectinomycin cassette with overlapping regions (indicated in
TABLE 1 Strains and primers used in this study
Strain(s) or primer Description or sequencea Reference(s)
Strains
01/1, 02/28, 03/03, 03/05p, 03/09, 03/30, 05/02, 06/1, 06/6, 10/03, 10/12, 11/06,
13/04, 16/11, 16/16, 18/02, 18/14, 19/01, 19/04, 19/11, 21/04, 23/03, 24/01,
26/04, 29/01, 31/4, 35/1, 35/42, 36/1
NTHi isolates from oropharynx of healthy children
in day care centers
This study
MEF_C001, MEF_C004, MEF_C006, MEF_C008, MEF_C009, MEF_C013,
MEF_C031, MEF_C049, MEF_C052, MEF_C062, MEF_C089-42k,
MEF_C089-32j, MEF_C101, MEF_C109, MEF_C115, MEF_R006,
MEF_R015, MEF_R020, MEF_R021-1, MEF_R021-2, MEF_R033,
MEF_R035, MEF_R038, MEF_R047, MEF_R048
NTHi isolates from middle ear fluid of children
with otitis media
29, 45
2-2, 8-3, 11-1, 11-2, 11-3, 12-7, 14-1, 14-5, 19-1, 27-1, 27-2, 33-1, 34-1, 34-2,
35-1, 35-2, 36-1, 36-2, 36-4, 41-2, 42-1, 44-1, 44-2, 44-3, 51-2, 51-3, 71-2
NTHi isolates from sputum samples collected from
COPD patients
This study
747, 1298, 1399, 1509, 1532, 1608, 1657, 1755, 2027, 2034, 2082, 2195, 2213,
2215, 2217, 2340, 2377, 2400, 2488, 2580, 2619, 2720, 2739, 2810, 2885,
3272, 3437, 3495, 3499, 3673
NTHi isolates from sputum samples of patients
with community-acquired pneumonia
This study
MEF_C008 licA C008 strain with the licA gene replaced by a Specr
cassette
This study
14-1 licA 14-1 strain with the licA gene replaced by a Specr
cassette
This study
01/1 licA 01/1 strain with the licA gene replaced by a Specr
cassette
This study
16/16 licA 16/16 strain with the licA gene replaced by a Specr
cassette
This study
2215 licA 2215 strain with the licA gene replaced by a Specr
cassette
This study
Rd Nonencapsulated type D strain 46
H446 Rd with lic1D::Km, constitutively PCho 38
H457 Rd with lic1D Eagan, PCho on HepIII 38
H491 Rd with lic1A (CAAT)n, constitutively PCho
,
PCho on HepI
38
Primers
R2866_1107_L1 GCTTGGTTTACCGAACGAAA This study
R2866_1107_L2 CCACTAGTTCTAGAGCGGCTGGAGGAAAAA
GGAATGGAA
This study
R2866_1107_R1 AGGCCTGCTGCTAAAATGAT This study
R2866_1107_R2 GCGTCAATTCGAGGGGTATCAAAACGCTTA
GACGCAGCAT
This study
R2866_1107_C TGGAGTTTGATTGATTGATTGA This study
PBpR412_L GCCGCTCTAGAACTAGTGG 47
PBpR412_R GATACCCCTCGAATTGACGC 47
a Italic type indicates the overlapping regions of the flanking regions of the R2866 licA gene and the spectinomycin cassette.
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italic type in Table 1) were PCR amplified and purified with the Qiagen
PCR purification kit (Qiagen). Equimolar concentrations of the flanking
regions and spectinomycin cassette were linked together in a second PCR.
The megaprimer PCR product amplified from strain R2866 was used to
transform M-IV competent NTHi as described previously (27). Strains
C008, 14-1, 1/1, 16/16, and 2215 were selected because of their successful
transformation.
LOS analysis by Tris-Tricine SDS-PAGE. LOS extraction was per-
formed by the proteinase K-ethanol precipitation method as described
previously (28). NTHiwas grown to anOD620 of0.6, and 1ml of culture
was washed twice with phosphate-buffered saline (PBS). The bacterial
pellet was lysed in 150l lysis buffer (60mMTris [pH6.8], 10mMEDTA,
2% SDS) and boiled for 5 min. Proteinase K (2.5g/ml) was added to the
cooled samples and incubated for 16 to 24 h at 37°C. Samples were pre-
cipitated by adding 20 l 3 M sodium acetate (pH 3.0) and 400 l 100%
ethanol, incubated for 1 h at20°C, and centrifuged for 5min at 15,000
g. Pellets were washed twice with 500 l 70% ethanol and suspended in
180l H2O. LOS samples were separated on a Tris-Tricine SDS-PAGE gel
with a Protean II xi cell electrophoresis system (Bio-Rad) and visualized
by silver staining or transferred onto a polyvinylidene difluoride (PVDF)
membrane for Western blotting with monoclonal antibody (MAb)
TEPC-15 to detect PCho.
Silver staining. Tris-Tricine gel was fixed for 1 h (45% methanol,
10% acetic acid), washed 3 times for 20 min with 50% methanol, and
incubated for 1 min in sensitizing solution (0.02% sodium thiosul-
fate). The gel was washed 3 times with distilled water and incubated for
20 min in impregnation solution (0.2% silver nitrate, 0.075% formal-
dehyde). After the gel was washed twice with distilled water, it was
treated with develop solution (6% sodium carbonate, 0.02% sodium
thiosulfate, 0.05% formaldehyde) until the bands were clearly visible.
Development was stopped by incubation in 0.1% acetic acid followed
by a 30-min wash with distilled water.
Western blot analysis. PVDF membranes were blocked with 5% bo-
vine serum albumin (BSA) in PBS, incubated for 2 h with TEPC-15 (1:
1,000), washed five times for 5 min with PBS plus 0.1% Tween, and sub-
sequently incubated with rabbit anti-mouse Ig (1:5,000) in PBS.
Membraneswerewashed 5 times for 5minwith PBS plus 0.1%Tween and
detected with ECL Plus reagent (GE Healthcare).
Complement resistance. Experiments were conducted with pooled
normal human serum (NHS) obtained from GTI Diagnostics (catalog
number PHS-N100), as described previously (29). NTHi was grown in
supplemented BHI medium to an OD620 of0.5, washed once with PBS,
and diluted to an OD620 of 0.1 in PBS-Hanks’ balanced salt solution
(HBSS) without phenol red containing Ca2/Mg2 (60% PBS–40%
HBSS). Samples were finally diluted 10,000-fold in PBS-HBSS to obtain a
concentration of 20,000 CFU/ml. Fifty microliters of the bacterial cul-
ture was mixed with 50 l 10% NHS or 10% heat-inactivated NHS (HI-
NHS), diluted in PBS-HBSS, and incubated for 1 h at 37°C. Serial dilu-
tions were plated onto sBHI plates and incubated overnight at 37°C in 5%
CO2. Survival was determined by dividing the CFU counts in 5% NHS
with the CFU counts in HI-NHS after 1 h of incubation.
Flow cytometry analysis.NTHiwas grown in supplemented BHIme-
dium to an OD620 of 0.5, or NTHi cells present in biofilms after 24 h
were scraped from the plate and suspended vigorously by pipetting up and
down. TEPC-15 and C-reactive protein (CRP) binding was detected by
flow cytometry, as previously described (30). HBSS without phenol red
and Ca2/Mg2, containing 5% (vol/vol) heat-inactivated fetal calf se-
rum, was used for all dilutions and washes. Surface opsonization was
performed by incubating 100 l bacteria at an OD620 of 0.5 (mid-log
growth) with 10g/ml TEPC-15 (Sigma) or 5%NHS for 1 h at 37°C with
5%CO2. Bacteria were fixed for 20min in 2% paraformaldehyde at room
temperature, and surface-bound TEPC-15 or CRP was detected by using
1:200-diluted anti-mouse IgA fluorescein isothiocyanate (FITC)-conju-
gated antibody (Sigma) or 1:100-diluted goat anti-human CRP (Sigma)
and 1:500-diluted donkey anti-goat Alexa 488-conjugated antibody (Life
Technology) by flow cytometry using a FACS LSR II instrument (BD
Biosciences, San Jose, CA, USA) shown as mean fluorescence intensity
(MFI) in arbitrary units (AU). Data were analyzed by using FlowJo ver-
sion 7.6.3.
Statistical analysis. Statistical analyses were performed with Graph-
Pad Prism version 4, where a P value of0.05 was considered significant.
The specific statistical tests that were used for the various experiments are
specified in the figure legends.
RESULTS AND DISCUSSION
Phosphorylcholine content and level of biofilm formation of
clinical NTHi isolates. This study included a total of 111 NTHi
clinical isolates collected from patients with different diseases, in-
cluding OM, CAP, and COPD, as well as strains isolated from
healthy colonized children. Growth of the isolates was consistent
and not statistically different between the groups (Fig. 1A). As
shown in Fig. 1B, isolates recovered from middle ear fluid of pa-
tients with OM showed statistically significant increased levels of
biofilm formation compared to isolates from healthy children. In
contrast, isolates from sputum samples of CAP and COPD pa-
tients presented statistically significant decreased levels of biofilm
formation compared to OM isolates. The level of biofilm forma-
tion of CAP and COPD isolates was lower than that of isolates
FIG 1 Growth, phosphorylcholine levels, and levels of biofilm formation for 111 clinical NTHi strains. Overnight growthmeasured by the optical density at 620
nm (OD620) (A), the level of biofilm formation measured by crystal violet light absorbance at 560 nm (A560) (B), and PCho content of planktonically grown
bacteria measured by binding of TEPC-15 by flow cytometry shown as mean fluorescence intensity (MFI) in arbitrary units (AU) (C) of NTHi isolates from
healthy children, childrenwith otitismedia (OM), adultswith chronic obstructive pulmonary disease (COPD), and adultswith community-acquired pneumonia
(CAP) are shown.Means	 standard errors of themeans of three independent replicates are depicted. One-way analysis of variance (P
 0.2458 [A], P
 0.0005
[B], and P
 0.0002 [C]) with the Newman-Keuls multiple-comparison post hoc test was used for statistical analysis (, P 0.05; , P 0.01; , P 0.001).
AU, arbitrary units.
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from healthy children, although this did not meet statistical sig-
nificance.
Isolates collected from the middle ear fluid of patients showed
amodest but significant increase in the level of biofilm formation.
These results, to some extent, corroborate the results reported by
Torretta and coworkers, who showed that biofilm-producing
NTHi isolates were present in the nasopharynx of children with
recurrent acute OM (22). More striking was the reduced level of
biofilm formation by NTHi isolates collected from patients with
CAP and COPD. Previously, Murphy and Kirkham showed high
variability in the level of biofilm formation but overall showed no
association between the source of the sample and biofilm forma-
tion (21). Our results imply that isolates from sputum samples
from adult patients with COPD or CAP behave differently from
isolates collected from the oropharynx and middle ear fluid of
children. Whether this is dependent on the age of the patients,
location of isolation, or type of inflammatory disease is thus far
not known.
The presence of PCho on NTHi grown planktonically was
measured byMAbTEPC-15 staining by flow cytometry. PCho is a
molecule present on a large number of microorganisms (31).
NTHi acquires choline from the environment, which is incorpo-
rated into its LOS in the form of PCho, which is regulated by the
phase-variable lic operon (32). NTHi isolates showed variations in
PCho integration into the LOS, being generally higher in strains
isolated from healthy children and children with OM than in iso-
lates obtained from COPD and CAP patients (Fig. 1C). This ob-
servation could be explained by PCho phase variation, as it has
been shown that incorporation of PCho favors colonization and
OM in an animalmodel and recently also in a human colonization
model (33–35). A possible factor explaining decreased PCho levels
in NTHi isolates collected from CAP and COPD patients is that
PCho binds C-reactive protein (CRP), which initiates comple-
ment-mediated killing of NTHi (35). A detectable level of CRP
was present in sputum samples of COPD patients (36), whereas it
was not detected in 30 out of 31 middle ear fluid samples of pa-
tients with OM (37). Therefore, NTHi present in the lungs of
COPD or CAP patients might decrease PCho incorporation into
the LOS in response to increased levels of CRP, thereby preventing
complement-mediated killing.
Phosphorylcholine content is not related to the level of bio-
film formation of clinical NTHi isolates in a static assay. The
evaluation of biofilm formation and PCho incorporation in the
LOS of 111 NTHi isolates enabled us to test whether there was a
positive relationship between these two conditions. Strains ob-
tained from healthy children showed a very modest (r2
 0.1917)
but significant (P 
 0.0175) negative correlation (Fig. 2A),
whereas no significant correlation between the presence of PCho
and biofilm formation was observed for strains isolated from chil-
dren with OM and patients with CAP and COPD (Fig. 2B to D).
The combination of all strains (n 
 111) also showed no signifi-
cant correlation between the presence of PCho and the level of
biofilm formation (Fig. 2E). In addition, when strains were
grouped into four quarters based on PCho expression (quarter 1
[Q1], TEPC-15 mean fluorescence intensity [MFI] in arbitrary
units [AU] of 1,254 to 221 AU; Q2, TEPC-15 MFI of 214 to 105
FIG 2 Correlation between phosphorylcholine levels and levels of biofilm formation for 111 clinical NTHi isolates. Shown is the correlation between the level
of biofilm formation measured by the A560 and the PCho content of planktonically grown bacteria measured by flow cytometry shown as mean fluorescence
intensity (MFI) in arbitrary units (AU). (A) NTHi strains from healthy children. (B) NTHi strains from patients with OM. (C) NTHi strains from patients with
CAP. (D) NTHi strains from patients with COPD. (E) All NTHi strains combined. (F) Level of biofilm formation measured by crystal violet A560 of strains with
high (Q1, TEPC-15MFI of 1,254 to 221 AU),mediumhigh (Q2, TEPC-15MFI of 214 to 105 AU),medium low (Q3, TEPC-15MFI of 104 to 46 AU), or low (Q4,
TEPC-15 MFI of 45 to 7 AU) PCho levels. Means	 standard errors of the means of three independent replicates are depicted. One-way analysis of variance (P

 0.4864 [F]) with the Newman-Keuls multiple-comparison post hoc test was used for statistical analysis.
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AU,Q3, TEPC-15MFI of 104 to 46AU;Q4, TEPC-15MFI of 45 to
7 AU), no differences in the level of biofilm formation were ob-
served.
Different effects of the presence of PCho on NTHi biofilm
initiation, formation, andmaturation have been observed in static
and continuous flow systems previously. It is likely that differ-
ences in NTHi strains and biofilm techniques used influence the
outcome of the effect of PCho in biofilm assays. For instance,
Hong et al. showed a positive correlation between the presence of
PCho in the LOS of three variants ofNTHi strain 2019 and biofilm
maturation in a continuous flow system (19).More representative
for our experiments, static biofilm experiments performed with
strains 86-028NP and 2019 showed no effects of PCho on biofilm
initiation after 10 hours. Therefore, additional experiments were
performed to evaluate the relationship between PCho incorpora-
tion and the level of biofilm formation in a static assay in more
detail by modulating PCho incorporation into NTHi LOS.
Thepositionof phosphorylcholine inLOSdoesnot affect the
level of biofilm formation. Incorporation of PCho can occur at
multiple positions in NTHi LOS. For example, PCho can be in-
corporated as a terminal moiety on hexoses extending heptose I
(HepI) or heptose III (HepIII), which differentially affects CRP
(38) and IgG (39) binding to NTHi. To our knowledge, whether
the HepI or HepIII position of PCho affects biofilm formation is
not known. Therefore, we tested the level of biofilm formation for
strains Rd (phase-variable incorporation of PCho onHepI), H446
(constitutively PCho), H457 (lic1D of the Eagan strain; PCho on
HepIII), andH491 (constitutively PCho onHepI).We found no
differences in growth (Fig. 3A) or the level of biofilm formation
(Fig. 3B) between Rd, H491 with PCho onHepI, H457 with PCho
incorporated into HepIII, and the constitutively PCho-negative
strain H446. These results demonstrate that the level of biofilm
formation is not affected by the presence or position of PCho into
the LOS of strain Rd.
Phosphorylcholine content inbacteriawithinabiofilmisnot
related to the level of biofilm formation of clinical NTHi iso-
lates. Since other studies demonstrated that the PCho content
was increased in bacteria growing within a biofilm structure
(40), we determined the amount of PCho present in 32 NTHi
strains in the planktonic or biofilm state of growth by flow
cytometry and analyzed the relationship with the level of bio-
film formation.
All the tested strains showed increased PCho content in a bio-
film compared to planktonic growth (Fig. 4A), and the PCho con-
tents of individual strains in either a planktonic culture or biofilm
showed a significant correlation (Fig. 4B). However, we have to
mention that it is very likely that we still had sufficient bacterial
clumping in the biofilm preparations despite vigorous shearing by
pipetting, which increases TEPC-15 binding per particle mea-
sured by flow cytometry. Although we attempted to loosen the
bacteria in the biofilm samples by vigorous shearing, forward and
sideward scatter signals were increased for the biofilm samples
(data not shown), which shows the presence of larger particles.
Therefore, the PCho content for NTHi samples present in a bio-
film might also be higher because of clumping. Nevertheless, as
described for planktonic cells (Fig. 4C), no correlation was ob-
served between the PCho content in NTHi strains present in a
biofilm and the level of biofilm formation of the particular strain
(Fig. 4D). These results show that although the PCho content
might be increased within the biofilm, the level of PCho is not
related to the level of biofilm formation.
Modulation of phosphorylcholine incorporation affects
complement resistance and the level of biofilm formation. In
order to address the effects of PCho in the LOSofNTHi on biofilm
formation, we constructed five mutant strains by replacement of
the licA gene with a spectinomycin cassette, which was confirmed
by PCR analysis. Replacement of the licA gene by a spectinomycin
cassette did not affect growth (data not shown). The PCho content
of the WT and licA mutants was determined by flow cytometry
and Western blotting. Flow cytometry analysis confirmed that all
licA mutants (Fig. 5A, light gray) presented an absence of PCho
compared to the WT strains (Fig. 5A, dark gray), which was sig-
FIG 3 Incorporation of phosphorylcholine on HepI or HepIII extension in
LOS does not alter the level of biofilm formation. Overnight growthmeasured
by the OD620 (A) and the level of biofilm formation by strains Rd (phase-
variable PCho on HepI), H446 (constitutively PCho), H457 (PCho on
HepIII), and H491 (constitutively PCho on HepI) measured by the A560 (B)
are shown. Means	 standard errors of the means of four independent repli-
cates are depicted. One-way analysis of variance (P 
 0.2461 [A] and P 

0.5727 [B]) with Tukey’s multiple-comparison post hoc test was used for sta-
tistical analysis.
FIG 4 Phosphorylcholine levels onNTHi grown planktonically or in a biofilm
shown as mean fluorescence intensity (MFI) in arbitrary units (AU) and the
level of biofilm formation. (A) PCho contents of 32NTHi strains grownplank-
tonically or in a biofilm. (B) Correlation between PCho content of NTHi
grown planktonically and in a biofilm. (C) Correlation between the level of
biofilm formation and PCho content of NTHi grown planktonically. (D) Cor-
relation between the level of biofilm formation and PCho content of NTHi
grown in a biofilm.
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nificant for 4 out of 5 strains (Fig. 5B). Western blot analysis re-
sults corroborated the flow cytometry data, with clearly abrogated
incorporation of PCho into the LOS of the licA gene deletion
mutants (Fig. 5C).
PCho has been shown to affect the virulence of NTHi by mul-
tiple mechanisms. For instance, PCho was shown to prevent IgG
binding, thereby preventing complement-mediated killing (39).
However, PCho also binds CRP, which induces classical comple-
ment pathway activation (35). Therefore, we determined the
effects of licAdeletion on resistance to complement-mediated kill-
ing in pooled normal human serum (NHS) and observed strain-
dependent changes. Strains C008, 14-1, 1/1, and 16/16 showed
decreased resistance to complement-mediated killing, whereas
strain 2215 showed increased resistance (Fig. 6A). The latter strain
showed binding to CRP (Fig. 6B) that was significantly reduced
upon licA deletion, which corresponds to its increased resistance
to complement-mediated killing.
Finally, we analyzed the effect of decreased PCho incorpora-
tion into LOS on biofilm formation. Biofilm formation showed
high variability among the fiveWTNTHi strains and their respec-
tive licA mutants (Fig. 7A). The 1/1 licA mutant strain formed
slightly less biofilm than the WT, although it was not significant.
In contrast, theC008 and 16/16 licAmutants formedmore biofilm
than the WT, whereas the 14-1 and 2215 licA mutants formed
approximately the same amount of biofilm, which is in line with
other static biofilm experiments with strains 86-028NP and 2019
(40).
The fact that the licA deletion affects the level biofilm forma-
tion either positively or negatively might be related to strain-de-
pendent alterations in LOS size or charge. As seen for the 14-1 and
16/16 licAmutants, LOS appeared to be slightly altered compared
to that of the WT, whereas this was not the case for the other
strains. Additionally, alterations in the overall surface charge of
NTHi might affect bacterial adhesion and biofilm formation, as
was observed for a wide variety of other bacterial species, includ-
ing Staphylococcus aureus (41), Enterococcus faecalis (42), and
Campylobacter jejuni (43). PCho has a positively charged quater-
nary amine group, and depletion of PCho in the licA mutant
might affect the overall surface charge depending on the amount
of PCho and other charged molecules on the surface of the WT
FIG 5 Effect of licA deletion on phosphorylcholine incorporation into NTHi LOS. (A) PCho contents in 5 NTHi WT and licA mutant strains detected by
TEPC-15 binding by flow cytometry in a representative experiment used for analysis in panel B. Solid and dotted black lines are the second antibody
controls for the WT and the licA mutant, respectively. In dark gray and light gray are TEPC-15 binding with the second antibodies for the WT and licA
mutant strains, respectively. The y axis depicts the relative number of events, and the x axis depicts the FITC mean fluorescence intensity (MFI) in
arbitrary units (AU). (B) PCho content in 5 NTHi WT and licA mutant strains detected by TEPC-15 binding by flow cytometry. Means	 standard errors
of the means of two independent replicates are depicted. A two-way analysis of variance with a Bonferroni post hoc test was used for statistical analysis (,
P  0.05; , P  0.01; , P  0.001; NS, not significant). (C) Analysis of LOS purified from licA mutants separated by Tris-Tricine SDS-PAGE and
visualized by silver staining or by Western blotting using TEPC-15 antibody.
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strain. Therefore, we tested biofilm formation on glass, since it was
shown previously that changes in charge affected adhesion to glass
or plastic differently (44). Overall, the ability of the WT and licA
mutants to form biofilm on glass (Fig. 7B) was similar to the re-
sults obtained on plastic (Fig. 7A). Altogether, we show that alter-
ations in PCho affect the level of NTHi biofilm formation in a
strain-dependent manner.
Conclusion. An understanding of which general factors are
involved in NTHi biofilm formation is an important topic for
future research because this knowledgewill allow a better compre-
FIG 6 Effect of licA deletion on CRP binding and complement resistance. (A) Survival of 5 NTHi WT and licA mutant strains in 5% NHS compared to 5%
HI-NHS for 1 h. Means	 standard errors of the means of four independent replicates are depicted. A Student t test was used for statistical analysis (, P 0.05;
, P 0.01; NS, not significant). (B) CRP binding to 5 NTHi WT and licA mutant strains measured by flow cytometry shown as mean fluorescence intensity
(MFI) in arbitrary units (AU). Means 	 standard errors of the means of four independent replicates are depicted. A two-way analysis of variance with a
Bonferroni post hoc test was used for statistical analysis.
FIG 7 Effect of licA deletion on the level of biofilm formation in vitro. The level of biofilm formation of the WT and licAmutant strains on plastic (A) and glass
(B) was measured by crystal violet A560. Means	 standard errors of the means of four (plastic) or three (glass) independent replicates are depicted. A Student
t test was used for statistical analysis (, P 0.05; , P 0.01; NS, not significant).
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hension of the infection process, which is important for the eval-
uation and treatment of diseases caused by NTHi. Our work
shows that incorporation of PCho into the LOS of clinical NTHi
isolates does not predict the level of biofilm in vitro. We observed
decreased biofilm formation in a static assay for the licAmutant of
strain 1/1; however, strains C008 and 16/16 showed increased bio-
film formation upon deletion of PCho incorporation. Therefore,
we conclude that PCho in NTHi LOS affects the level biofilm
formation in a strain-dependent manner and that its presence
does not predict the ability to form biofilms in a static assay in
vitro.
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